MEI PHARMA INC (MEIP)

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

MEI Pharma files for $100M mixed shelf (NASDAQ:MEIP)

MEI Pharma files prospectus for mixed securities shelf offering of up to $100M.

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

Glancy Prongay & Murray LLP Announces Investigation of MEI Pharma, Inc. (MEIP)

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

MEI Pharma Recommends Stockholders Not to Consent

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Infinity Pharmaceuticals reportedly files for Chapter 11 (OTCMKTS:INFI)

Infinity Pharmaceuticals (INFI) has reportedly filed for bankruptcy in the wake of the termination of its merger deal with MEI Pharma.

MEI Pharma Issues Statement Regarding Anson and Cable Car’s Opportunistic Actions

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

MEI Pharma Announces Results of Special Meeting of Stockholders

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

MEI Pharma Responds to Anson and Cable Car

Anson and Cable Car File Preliminary Consent Materials to Remove Entire Board of Directors at MEI Pharma, Inc.

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

MEI Pharma postpones special meeting to vote on Infinity deal until July 23

MEI Pharma Inc. (MEIP) postponed a special meeting for holders to vote on its merger with Infinity Pharmaceuticals (INFI).  The holder vote was postponed to July 23 from a scheduled vote...

MEI Pharma Postpones Special Meeting of Shareholders

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

Proxy advisor ISS recommends MEI, Infinity shareholders approve merger (NASDAQ:MEIP)

Institutional Shareholder Services has recommended that MEI Pharma (MEIP) and Infinity Pharmaceuticals (INFI) shareholders vote in favor of their planned merger. Read more here.

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals